Aggressive PDACs Show Hypomethylation of Repetitive Elements and the Execution of an Intrinsic IFN Program Linked to a Ductal Cell of Origin.


Journal

Cancer discovery
ISSN: 2159-8290
Titre abrégé: Cancer Discov
Pays: United States
ID NLM: 101561693

Informations de publication

Date de publication:
03 2021
Historique:
received: 18 08 2020
revised: 24 09 2020
accepted: 25 09 2020
pubmed: 17 10 2020
medline: 20 1 2022
entrez: 16 10 2020
Statut: ppublish

Résumé

Pancreatic ductal adenocarcinoma (PDAC) is characterized by extensive desmoplasia, which challenges the molecular analyses of bulk tumor samples. Here we FACS-purified epithelial cells from human PDAC and normal pancreas and derived their genome-wide transcriptome and DNA methylome landscapes. Clustering based on DNA methylation revealed two distinct PDAC groups displaying different methylation patterns at regions encoding repeat elements. Methylation

Identifiants

pubmed: 33060108
pii: 2159-8290.CD-20-1202
doi: 10.1158/2159-8290.CD-20-1202
pmc: PMC9216338
mid: NIHMS1634719
doi:

Substances chimiques

Interferons 9008-11-1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

638-659

Subventions

Organisme : Intramural NIH HHS
ID : ZIA BC011798
Pays : United States
Organisme : CIHR
Pays : Canada

Informations de copyright

©2020 American Association for Cancer Research.

Références

Nature. 2014 Jun 26;510(7506):537-41
pubmed: 24847876
Cell. 2017 Oct 5;171(2):321-330.e14
pubmed: 28965763
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Cell. 2018 Jul 26;174(3):549-563.e19
pubmed: 29937226
Bioinformatics. 2013 Jan 15;29(2):189-96
pubmed: 23175756
Am J Pathol. 1992 Mar;140(3):559-68
pubmed: 1372155
Genes Dev. 2011 Sep 15;25(18):1915-27
pubmed: 21890647
Elife. 2018 May 11;7:
pubmed: 29749927
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Cancer Cell. 2014 Jun 16;25(6):719-34
pubmed: 24856586
Science. 2011 Feb 4;331(6017):593-6
pubmed: 21233348
Nat Med. 2018 Aug;24(8):1143-1150
pubmed: 30038220
Cancer Discov. 2019 Feb;9(2):282-301
pubmed: 30366930
Oncotarget. 2016 Apr 26;7(17):23263-81
pubmed: 26993610
Biochim Biophys Acta. 2013 Nov;1829(11):1161-74
pubmed: 23938249
Pancreas. 2014 Oct;43(7):1073-7
pubmed: 24987871
Clin Cancer Res. 2011 Jul 1;17(13):4341-54
pubmed: 21610144
Sci Rep. 2019 Mar 11;9(1):4040
pubmed: 30858455
Nat Rev Cancer. 2016 Mar;16(3):131-44
pubmed: 26911188
Cancer Cell. 2010 Feb 17;17(2):135-47
pubmed: 20138012
Proc Natl Acad Sci U S A. 2018 Feb 06;115(6):E1147-E1156
pubmed: 29351990
Cancer Cell. 2019 Feb 11;35(2):267-282.e7
pubmed: 30686769
Gut. 2019 Mar;68(3):487-498
pubmed: 29363536
Cell Rep. 2017 Nov 28;21(9):2458-2470
pubmed: 29186684
Cancer Cell. 2014 Jun 16;25(6):735-47
pubmed: 24856585
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
BMC Bioinformatics. 2015 May 22;16:169
pubmed: 25994840
Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):E89-98
pubmed: 23236145
Genome Biol. 2012 Oct 03;13(10):R83
pubmed: 23034175
Nat Genet. 2012 Nov;44(11):1236-42
pubmed: 23064414
Epigenomics. 2016 Mar;8(3):389-99
pubmed: 26673039
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Exp Med. 2017 Mar 6;214(3):579-596
pubmed: 28232471
Gastroenterology. 2018 Dec;155(6):1999-2013.e3
pubmed: 30165049
EMBO J. 2016 Mar 15;35(6):595-617
pubmed: 26769127
Nat Genet. 2020 Feb;52(2):231-240
pubmed: 31932696
Nat Protoc. 2013;8(7):1354-65
pubmed: 23787893
Invest New Drugs. 2018 Aug;36(4):683-695
pubmed: 29508247
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Cancer Res. 2003 Jul 1;63(13):3735-42
pubmed: 12839967
Cancer Discov. 2019 Aug;9(8):1102-1123
pubmed: 31197017
Pathobiology. 2017;84(4):192-201
pubmed: 28291966
Nat Commun. 2018 Feb 8;9(1):577
pubmed: 29422656
J Transl Med. 2010 Jan 29;8:10
pubmed: 20113473
Nature. 2016 Mar 3;531(7592):47-52
pubmed: 26909576
Sci Rep. 2018 Jun 15;8(1):9227
pubmed: 29907753
Nat Commun. 2018 May 17;9(1):1978
pubmed: 29773832
Cell Rep. 2013 Dec 26;5(6):1704-13
pubmed: 24332856
Development. 2015 Sep 15;142(18):3126-37
pubmed: 26395141
Development. 2005 Aug;132(16):3767-76
pubmed: 16020518
Trends Immunol. 2015 Nov;36(11):725-737
pubmed: 26604042
Cell Stem Cell. 2014 Oct 2;15(4):507-522
pubmed: 25158935
Nature. 1983 Jan 6;301(5895):89-92
pubmed: 6185846
Nucleic Acids Res. 2012 May;40(9):e69
pubmed: 22302147
Methods Mol Biol. 2018;1708:105-122
pubmed: 29224141
Cancer Cell. 2007 Mar;11(3):291-302
pubmed: 17349585
J Clin Oncol. 2015 Dec 1;33(34):4039-47
pubmed: 26351344
Nat Immunol. 2017 Oct;18(10):1160-1172
pubmed: 28783152
Histopathology. 2014 Sep;65(3):389-97
pubmed: 24931343
Clin Cancer Res. 2019 Apr 1;25(7):2194-2205
pubmed: 30385653
Bioinformatics. 2016 May 15;32(10):1446-53
pubmed: 26819470
Nature. 2015 Feb 19;518(7539):317-30
pubmed: 25693563
Nat Genet. 2015 Oct;47(10):1168-78
pubmed: 26343385
Elife. 2020 Apr 24;9:
pubmed: 32329713
Cell. 2017 Sep 7;170(6):1062-1078
pubmed: 28886379
Science. 1996 Jan 19;271(5247):350-3
pubmed: 8553070
Cell Rep. 2018 Nov 13;25(7):1741-1755.e7
pubmed: 30428345
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Nature. 2019 Jan;565(7737):43-48
pubmed: 30559380
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Nat Genet. 2017 Jul;49(7):1052-1060
pubmed: 28604729
Nat Genet. 2003 Jul;34(3):267-73
pubmed: 12808457
Cancer Cell. 2012 Nov 13;22(5):571-84
pubmed: 23153532
Nat Protoc. 2013 Oct;8(10):2022-32
pubmed: 24071908
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Mol Oncol. 2009 Dec;3(5-6):425-38
pubmed: 19497796
Cell Rep. 2018 Jun 12;23(11):3407-3418
pubmed: 29898408
Oncogene. 2016 Aug 11;35(32):4282-8
pubmed: 26592447
Cell. 2016 Dec 1;167(6):1540-1554.e12
pubmed: 27912061
Nat Cancer. 2020 Jan;1(1):59-74
pubmed: 35118421
Gastroenterology. 2007 Dec;133(6):1999-2009
pubmed: 18054571
Am J Pathol. 1996 Jun;148(6):1763-70
pubmed: 8669463
Int J Cancer. 2014 Sep 1;135(5):1110-8
pubmed: 24500968
Nucleic Acids Res. 2017 Nov 16;45(20):11622-11642
pubmed: 28977426
Nat Biotechnol. 2020 Mar;38(3):333-342
pubmed: 31932730
Nat Med. 2011 Apr;17(4):500-3
pubmed: 21460848
Nat Genet. 2011 Nov 27;44(1):40-6
pubmed: 22120008
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nat Genet. 2016 Mar;48(3):253-64
pubmed: 26780610
Nature. 2017 Aug 24;548(7668):471-475
pubmed: 28813415
Cell. 2015 Aug 27;162(5):961-73
pubmed: 26317465
Nat Rev Gastroenterol Hepatol. 2017 May;14(5):296-304
pubmed: 28270694
Cell Res. 2019 Sep;29(9):725-738
pubmed: 31273297
Nat Biotechnol. 2010 May;28(5):495-501
pubmed: 20436461
Clin Cancer Res. 2012 Aug 15;18(16):4266-76
pubmed: 22896693
Cancer Cell. 2012 Sep 11;22(3):318-30
pubmed: 22975375
Cancer Cell. 2017 Aug 14;32(2):185-203.e13
pubmed: 28810144
Am J Pathol. 2000 Nov;157(5):1623-31
pubmed: 11073822
Cell Syst. 2016 Oct 26;3(4):385-394.e3
pubmed: 27693023
Cell. 2014 Sep 25;159(1):80-93
pubmed: 25259922
Nucleic Acids Res. 1991 Jun 11;19(11):2993-3000
pubmed: 2057357
Nat Methods. 2014 Nov;11(11):1138-1140
pubmed: 25262207
Cell Stem Cell. 2015 Jan 8;16(1):18-31
pubmed: 25465113
Nat Cell Biol. 2014 Mar;16(3):255-67
pubmed: 24561622
Bioinformatics. 2016 Aug 1;32(15):2372-4
pubmed: 27153599
Nat Commun. 2018 Nov 29;9(1):5068
pubmed: 30498206
Cell Metab. 2016 May 10;23(5):909-20
pubmed: 27133132
Nature. 2019 May;569(7754):131-135
pubmed: 30996350
Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18913-8
pubmed: 19028870
Cell Syst. 2018 Sep 26;7(3):310-322.e4
pubmed: 30145115
Cell Metab. 2016 Oct 11;24(4):593-607
pubmed: 27667667
Cell Rep. 2017 Oct 24;21(4):966-978
pubmed: 29069604
Gut. 2019 Jun;68(6):1034-1043
pubmed: 30658994
Nat Med. 2016 Mar;22(3):278-87
pubmed: 26855150
Virology. 2013 Feb 5;436(1):221-34
pubmed: 23246628
Gut. 2012 Mar;61(3):449-58
pubmed: 21730103
Mol Cell. 2014 Dec 18;56(6):796-807
pubmed: 25435137
Gastroenterology. 2011 Aug;141(2):731-41, 741.e1-4
pubmed: 21703267
Cell. 2015 Aug 27;162(5):974-86
pubmed: 26317466
Front Oncol. 2014 Mar 27;4:62
pubmed: 24734219
Diabetologia. 1998 Jun;41(6):629-33
pubmed: 9662042
Science. 1981 Jun 19;212(4501):1350-7
pubmed: 6262918

Auteurs

Elisa Espinet (E)

HI-STEM-Heidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH, Heidelberg, Germany. a.trumpp@dkfz.de e.espinet@dkfz.de.
Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
German Cancer Consortium (DKTK), Heidelberg, Germany.

Zuguang Gu (Z)

Bioinformatics and Omics Data Analytics, DKFZ, Heidelberg, Germany.
Heidelberg Center for Personalized Oncology (DKFZ-HIPO), Heidelberg, Germany.

Charles D Imbusch (CD)

Division of Applied Bioinformatics, DKFZ and NCT, Heidelberg, Germany.

Nathalia A Giese (NA)

Department of General and Visceral Surgery, University Hospital Heidelberg, Heidelberg, Germany.

Magdalena Büscher (M)

HI-STEM-Heidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH, Heidelberg, Germany.
Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.

Mariam Safavi (M)

HI-STEM-Heidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH, Heidelberg, Germany.
Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.

Silke Weisenburger (S)

HI-STEM-Heidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH, Heidelberg, Germany.
Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.

Corinna Klein (C)

HI-STEM-Heidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH, Heidelberg, Germany.

Vanessa Vogel (V)

HI-STEM-Heidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH, Heidelberg, Germany.

Mattia Falcone (M)

HI-STEM-Heidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH, Heidelberg, Germany.
Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.

Jacob Insua-Rodríguez (J)

HI-STEM-Heidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH, Heidelberg, Germany.
Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.

Manuel Reitberger (M)

HI-STEM-Heidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH, Heidelberg, Germany.
Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.

Vera Thiel (V)

HI-STEM-Heidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH, Heidelberg, Germany.
Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.

Steffi O Kossi (SO)

HI-STEM-Heidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH, Heidelberg, Germany.

Alexander Muckenhuber (A)

Institute of Pathology, Technical University of Munich, Munich, Germany.

Karnjit Sarai (K)

Department of Cellular and Physiological Sciences, Life Science Institute, University of British Columbia, Vancouver, British Columbia, Canada.

Alex Y L Lee (AYL)

Department of Cellular and Physiological Sciences, Life Science Institute, University of British Columbia, Vancouver, British Columbia, Canada.

Elyne Backx (E)

Laboratory of Molecular and Medical Oncology, Vrije Universiteit Brussel, Brussels, Belgium.

Soheila Zarei (S)

Department of Cellular and Physiological Sciences, Life Science Institute, University of British Columbia, Vancouver, British Columbia, Canada.

Matthias M Gaida (MM)

Institute of Pathology, University Hospital of Heidelberg, Heidelberg, Germany.
Institute of Pathology, University Medical Center JGU Mainz, Mainz, Germany.

Manuel Rodríguez-Paredes (M)

Division of Epigenetics, DKFZ-ZMBH Alliance, DKFZ, Heidelberg, Germany.

Elisa Donato (E)

HI-STEM-Heidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH, Heidelberg, Germany.
Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.

Hsi-Yu Yen (HY)

Institute of Pathology, Technical University of Munich, Munich, Germany.

Roland Eils (R)

Heidelberg Center for Personalized Oncology (DKFZ-HIPO), Heidelberg, Germany.
Digital Health Centre, Berlin Institute of Health and Charité Universitätsmedizin Berlin, Berlin, Germany.
Health Data Science Unit, University Hospital and University of Heidelberg, Heidelberg, Germany.

Matthias Schlesner (M)

Bioinformatics and Omics Data Analytics, DKFZ, Heidelberg, Germany.

Nicole Pfarr (N)

Institute of Pathology, Technical University of Munich, Munich, Germany.

Thilo Hackert (T)

Department of General and Visceral Surgery, University Hospital Heidelberg, Heidelberg, Germany.

Christoph Plass (C)

Division of Cancer Epigenomics, DKFZ, Heidelberg, Germany.

Benedikt Brors (B)

German Cancer Consortium (DKTK), Heidelberg, Germany.
Division of Applied Bioinformatics, DKFZ and NCT, Heidelberg, Germany.

Katja Steiger (K)

German Cancer Consortium (DKTK), Heidelberg, Germany.
Institute of Pathology, Technical University of Munich, Munich, Germany.

Dieter Weichenhan (D)

Heidelberg Center for Personalized Oncology (DKFZ-HIPO), Heidelberg, Germany.

H Efsun Arda (HE)

Laboratory of Receptor Biology and Gene Expression, Center of Cancer Research, NCI, NIH, Bethesda, Maryland.

Ilse Rooman (I)

Laboratory of Molecular and Medical Oncology, Vrije Universiteit Brussel, Brussels, Belgium.

Janel L Kopp (JL)

Department of Cellular and Physiological Sciences, Life Science Institute, University of British Columbia, Vancouver, British Columbia, Canada.

Oliver Strobel (O)

Department of General and Visceral Surgery, University Hospital Heidelberg, Heidelberg, Germany.
National Center of Tumor Diseases, NCT, Heidelberg, Germany.

Wilko Weichert (W)

German Cancer Consortium (DKTK), Heidelberg, Germany.
Institute of Pathology, Technical University of Munich, Munich, Germany.

Martin R Sprick (MR)

HI-STEM-Heidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH, Heidelberg, Germany.
Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.

Andreas Trumpp (A)

HI-STEM-Heidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH, Heidelberg, Germany. a.trumpp@dkfz.de e.espinet@dkfz.de.
Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
German Cancer Consortium (DKTK), Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH